3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Papillomavirus Infections
1
Interventions
ranpirnase
1
fludarabine phosphate
1
fludarabine
1
aldesleukin
1
Respiratory Function Tests
1
Radiosurgery
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Meperidine
1
Magnetic Resonance Imaging
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Hydroxyzine
1
Granisetron
1
Electrocardiography
1
Droperidol
1
Doxylamine
1
Diphenoxylate
1
Diphenhydramine
1
Cyclophosphamide
1
Codeine
1
Cell Count
1
Carbon-14
1
Biopsy
1
Atropine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Papillomavirus Infections
×
Carbon-14
×
Clear all
NCT06672653
2024-11-04
PREPAP
MGB Pharma
Phase 1/2
Not yet recruiting
66 enrolled